- Home
- EMKR vs NTBL Comparison
EMKR vs NTBL Comparison
Compare EMKR & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMKR
- NTBL
- Stock Information
- Founded
- EMKR 1984
- NTBL 2000
- Country
- EMKR United States
- NTBL United States
- Employees
- EMKR N/A
- NTBL N/A
- Industry
- EMKR Semiconductors
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- EMKR Technology
- NTBL Health Care
- Exchange
- EMKR Nasdaq
- NTBL Nasdaq
- Market Cap
- EMKR 9.5M
- NTBL 4.6M
- IPO Year
- EMKR 1997
- NTBL N/A
- Fundamental
- Price
- EMKR $2.33
- NTBL $0.34
- Analyst Decision
- EMKR Buy
- NTBL Buy
- Analyst Count
- EMKR 2
- NTBL 2
- Target Price
- EMKR $3.00
- NTBL $5.00
- AVG Volume (30 Days)
- EMKR 2.0M
- NTBL 8.0M
- Earning Date
- EMKR 12-10-2024
- NTBL 11-12-2024
- Dividend Yield
- EMKR N/A
- NTBL N/A
- EPS Growth
- EMKR N/A
- NTBL N/A
- EPS
- EMKR N/A
- NTBL N/A
- Revenue
- EMKR $90,961,000.00
- NTBL $313,000.00
- Revenue This Year
- EMKR N/A
- NTBL N/A
- Revenue Next Year
- EMKR $7.07
- NTBL N/A
- P/E Ratio
- EMKR N/A
- NTBL N/A
- Revenue Growth
- EMKR 413.79
- NTBL 3812.50
- 52 Week Low
- EMKR $0.78
- NTBL $0.22
- 52 Week High
- EMKR $7.20
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- EMKR 67.47
- NTBL 43.04
- Support Level
- EMKR $2.07
- NTBL $0.28
- Resistance Level
- EMKR $2.54
- NTBL $0.67
- Average True Range (ATR)
- EMKR 0.16
- NTBL 0.06
- MACD
- EMKR -0.02
- NTBL -0.00
- Stochastic Oscillator
- EMKR 55.32
- NTBL 27.53
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.